Your browser doesn't support javascript.
loading
Persistent and Recurrent Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
Mesnier, Jules; Simard, Trevor; Jung, Richard G; Lehenbauer, Kyle R; Piayda, Kerstin; Pracon, Radoslaw; Jackson, Gregory G; Flores-Umanzor, Eduardo; Faroux, Laurent; Korsholm, Kasper; Chun, Julian K R; Chen, Shaojie; Maarse, Moniek; Montrella, Kristi; Chaker, Zakeih; Spoon, Jocelyn N; Pastormerlo, Luigi E; Meincke, Felix; Sawant, Abhishek C; Moldovan, Carmen M; Qintar, Mohammed; Aktas, Mehmet K; Branca, Luca; Radinovic, Andrea; Ram, Pradhum; El-Zein, Rayan S; Flautt, Thomas; Ding, Wern Yew; Sayegh, Bassel; Benito-González, Tomás; Lee, Oh-Hyun; Badejoko, Solomon O; Paitazoglou, Christina; Karim, Nabeela; Zaghloul, Ahmed M; Agarwal, Himanshu; Kaplan, Rachel M; Alli, Oluseun; Ahmed, Aamir; Suradi, Hussam S; Knight, Bradley P; Alla, Venkata M; Panaich, Sidakpal S; Wong, Tom; Bergmann, Martin W; Chothia, Rashaad; Kim, Jung-Sun; Pérez de Prado, Armando; Bazaz, Raveen; Gupta, Dhiraj.
Affiliation
  • Mesnier J; Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.
  • Simard T; Department of Cardiovascular Diseases, Mayo Clinic School of Medicine, Rochester, Minnesota, USA.
  • Jung RG; Capital Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
  • Lehenbauer KR; Division of Cardiology, Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA.
  • Piayda K; CardioVascular Center Frankfurt, Frankfurt, Germany; Department of Cardiology and Angiology, Universitätsklinikum Gießen und Marburg, Gießen, Germany.
  • Pracon R; Coronary and Structural Heart Diseases Department, National Institute of Cardiology, Warsaw, Poland.
  • Jackson GG; Vanderbilt Heart and Vascular Institute, Nashville, Tennessee, USA.
  • Flores-Umanzor E; Department of Cardiology, Hospital Clínic of Barcelona, August Pi i Sunyer Biomedical Research Institute, University of Barcelona, Barcelona, Spain.
  • Faroux L; Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.
  • Korsholm K; Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
  • Chun JKR; Cardioangiologisches Centrum Bethanien, Medizinische Klinik III, Markuskrankenhaus, Frankfurt, Germany.
  • Chen S; Cardioangiologisches Centrum Bethanien, Medizinische Klinik III, Markuskrankenhaus, Frankfurt, Germany.
  • Maarse M; Cardiology, St Antonius Hospital, Nieuwegein, the Netherlands; LB Amsterdam University Medical Center, Amsterdam, the Netherlands.
  • Montrella K; Heart and Vascular Institute, University of Pittsburgh Medical Center, University of Pittsburgh, Altoona, Pennsylvania, USA.
  • Chaker Z; Division of Cardiology, West Virginia School of Medicine, Morgantown, West Virginia, USA.
  • Spoon JN; International Heart Institute of Montana, Missoula, Montana, USA.
  • Pastormerlo LE; Fondazione Toscana Gabriele Monasterio Massa, Scuola Superiore Sant'Anna, Pisa, Italy.
  • Meincke F; Asklepios Klinik Altona, Hamburg, Germany.
  • Sawant AC; Chandler Regional Medical Center, Chandler, Arizona, USA.
  • Moldovan CM; Division of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland.
  • Qintar M; Division of Cardiology, Henry Ford Health System, Detroit, Michigan, USA; Department of Cardiology, Sparrow Hospital, Michigan State University, Lansing, Michigan.
  • Aktas MK; Division of Cardiology, University of Rochester Medical Center, Rochester, New York, USA.
  • Branca L; Cardiac Catheterization Laboratory and Cardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
  • Radinovic A; Arrhythmology Department, San Raffaele University Hospital, Milan, Italy.
  • Ram P; Emory University Hospital, Atlanta, Georgia, USA.
  • El-Zein RS; Division of Cardiology, OhioHealth Doctors Hospital/OhioHealth Riverside Methodist Hospital, Columbus, Ohio, USA.
  • Flautt T; Houston Methodist Hospital, Houston, Texas, USA.
  • Ding WY; Liverpool Heart and Chest Hospital, Liverpool, United Kingdom.
  • Sayegh B; Heart, Lung and Vascular Institute, Excela Health, Independence Health System, Pittsburgh, Pennsylvania, USA.
  • Benito-González T; Department of Cardiology, University Hospital of León, León, Spain.
  • Lee OH; Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Badejoko SO; Division of Internal Medicine, St Joseph's Medical Center (Dignity Health), Stockton, California, USA.
  • Paitazoglou C; Cardiologicum Hamburg, Hamburg, Germany.
  • Karim N; Royal Brompton and Harefield Hospitals, Part of Guys' and St Thomas' National Health Service Foundation Trust, London, United Kingdom.
  • Zaghloul AM; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.
  • Agarwal H; Creighton University School of Medicine, Omaha, Nebraska, USA.
  • Kaplan RM; Bluhm Cardiovascular Institute, Northwestern University, Chicago, Illinois, USA.
  • Alli O; Division of Cardiology, Novant Health Heart and Vascular Institute, Charlotte, North Carolina, USA.
  • Ahmed A; Rush University Medical Center, Chicago, Illinois, USA.
  • Suradi HS; Rush University Medical Center, Chicago, Illinois, USA.
  • Knight BP; Bluhm Cardiovascular Institute, Northwestern University, Chicago, Illinois, USA.
  • Alla VM; Creighton University School of Medicine, Omaha, Nebraska, USA.
  • Panaich SS; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.
  • Wong T; Royal Brompton and Harefield Hospitals, Part of Guys' and St Thomas' National Health Service Foundation Trust, London, United Kingdom.
  • Bergmann MW; Department of Cardiology, AK Altona, Hamburg, Germany.
  • Chothia R; Division of Internal Medicine, St Joseph's Medical Center (Dignity Health), Stockton, California, USA.
  • Kim JS; Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Pérez de Prado A; Department of Cardiology, University Hospital of León, León, Spain.
  • Bazaz R; Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Gupta D; Liverpool Heart and Chest Hospital, Liverpool, United Kingdom.
JACC Cardiovasc Interv ; 16(22): 2722-2732, 2023 Nov 27.
Article in En | MEDLINE | ID: mdl-38030358
BACKGROUND: Scarce data exist on the evolution of device-related thrombus (DRT) after left atrial appendage closure (LAAC). OBJECTIVES: This study sought to assess the incidence, predictors, and clinical impact of persistent and recurrent DRT in LAAC recipients. METHODS: Data were obtained from an international multicenter registry including 237 patients diagnosed with DRT after LAAC. Of these, 214 patients with a subsequent imaging examination after the initial diagnosis of DRT were included. Unfavorable evolution of DRT was defined as either persisting or recurrent DRT. RESULTS: DRT resolved in 153 (71.5%) cases and persisted in 61 (28.5%) cases. Larger DRT size (OR per 1-mm increase: 1.08; 95% CI: 1.02-1.15; P = 0.009) and female (OR: 2.44; 95% CI: 1.12-5.26; P = 0.02) were independently associated with persistent DRT. After DRT resolution, 82 (53.6%) of 153 patients had repeated device imaging, with 14 (17.1%) cases diagnosed with recurrent DRT. Overall, 75 (35.0%) patients had unfavorable evolution of DRT, and the sole predictor was average thrombus size at initial diagnosis (OR per 1-mm increase: 1.09; 95% CI: 1.03-1.16; P = 0.003), with an optimal cutoff size of 7 mm (OR: 2.51; 95% CI: 1.39-4.52; P = 0.002). Unfavorable evolution of DRT was associated with a higher rate of thromboembolic events compared with resolved DRT (26.7% vs 15.1%; HR: 2.13; 95% CI: 1.15-3.94; P = 0.02). CONCLUSIONS: About one-third of DRT events had an unfavorable evolution (either persisting or recurring), with a larger initial thrombus size (particularly >7 mm) portending an increased risk. Unfavorable evolution of DRT was associated with a 2-fold higher risk of thromboembolic events compared with resolved DRT.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Thromboembolism / Thrombosis / Atrial Appendage / Stroke Limits: Female / Humans Language: En Journal: JACC Cardiovasc Interv Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2023 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Thromboembolism / Thrombosis / Atrial Appendage / Stroke Limits: Female / Humans Language: En Journal: JACC Cardiovasc Interv Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2023 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos